Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases

Martyna Godzieba1, Slawomir Ciesielski1

  • 1Department of Environmental Biotechnology, Faculty of Environmental Sciences, University of Warmia and Mazury in Olsztyn, ul. Sloneczna 45 G, 10-917 Olsztyn, Poland.

Insights

Natural compounds, particularly DNA intercalators, offer promising therapeutic potential for combating cancer and infectious diseases due to their diverse structures and mechanisms. This research highlights natural intercalators as novel drug candidates against drug-resistant pathogens and cancer.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Cancer and infectious diseases pose significant global health challenges, exacerbated by lifestyle factors and increasing drug resistance.
  • Current therapies face limitations, driving the need for novel therapeutic agents with unique mechanisms of action.
  • Natural products have historically been and remain a vital source of diverse, biologically active compounds for drug discovery.

Purpose of the Study:

  • To explore the therapeutic potential of natural compounds as anticancer and antimicrobial agents.
  • To focus on DNA intercalators, a class of compounds that interact with nucleic acids.
  • To present promising natural intercalators that have garnered recent research interest.

Main Methods:

  • Review of scientific literature on natural product chemistry and pharmacology.
  • Focus on compounds exhibiting DNA intercalation as a mechanism of action.
  • Analysis of chemical structures and biological activities of identified natural intercalators.

Main Results:

  • Natural compounds possess diverse chemical structures and mechanisms, targeting various molecular pathways.
  • DNA intercalation represents a key interaction for anticancer and antimicrobial activity.
  • Several natural intercalators demonstrate significant therapeutic potential against challenging diseases.

Conclusions:

  • Natural intercalators are promising candidates for developing new treatments against cancer and infectious diseases.
  • Their unique ability to interact with DNA offers a strategy to overcome existing drug resistance.
  • Further research into natural intercalators could lead to novel chemotherapeutics.

Related Concept Videos

Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.5K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
908
DNA Helicases00:55

DNA Helicases

DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
23.7K